Dec 9 (Reuters) - Eli Lilly said on Tuesday it will invest more than $6 billion in a new active drug ingredient manufacturing facility in Huntsville, Alabama, to expand U.S. production and bolster medicine supply chains.
The site, the third new U.S. facility announced by Lilly, will make small-molecule synthetic and peptide medicines, including orforglipron, its first oral GLP-1 weight-loss drug anticipated to receive U.S. approval early next year.
Global pharmaceutical companies have been increasing U.S. investments after President Donald Trump urged the industry to make more medicines domestically rather than importing active ingredients or finished medicines.
Earlier this year, Lilly outlined plans to spend at least $27 billion on four new U.S. manufacturing sites to counter potential drug import duties. Lilly said another location will be announced in the coming weeks.
The company said the construction is slated to begin in 2026, creating about 3,000 construction jobs, with completion targeted for 2032. Lilly also plans 450 roles for engineers, scientists, operations personnel and lab technicians in the area.
CEO David Ricks said the investment advances the onshoring of active pharmaceutical ingredient production to strengthen supply resilience.
The company estimates every dollar invested could generate up to four dollars in local economic activity.
The site was chosen from more than 300 applications, aided by proximity to the HudsonAlpha Institute for Biotechnology, an established bioscience campus supporting workforce training and research, Lilly said.
Alabama Governor Kay Ivey called the project "the largest initial investment in our state's history."
Lilly said the plant will use machine learning, AI and digitally integrated monitoring systems, with automation embedded across operations.
The company also aims to work toward carbon neutrality at the site, said Edgardo Hernandez, Lilly's manufacturing operations head.
(Reporting by Puyaan Singh in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
As her kidneys fail and time runs short, this activist fights to decriminalize euthanasia in Mexico - 210 Fundamental Tips and Deceives to Lift Your Cell phone's Exhibition
- 3Public Parks in the USA
- 4Vote In favor of Your Number one Savvy Beds
- 5Qatar, Ireland accuse Israel of using chemical weapons on Palestinians, demand watchdog probe use
- 10 Moves toward Start Your Own Effective Business
- Grasping the Course of Evacuation and Extradition in U.S. Migration
- Rediscovering Euphoria: Individual Accounts of Conquering Despondency
- Defense Minister Katz finally condemns Jewish extremist violence against Palestinians
- Mont Blanc road tunnel reopens to traffic after 15 weeks of repairs
- US FDA approves Kura-Kyowa's blood cancer therapy
- Venus shines at its best in spring and summer 2026 — here's what to look for
- Figure out How to Keep up with and Clean Your Brilliant Bed for Ideal Execution
- Students were skipping my astrophysics class to play video games – so I turned the class itself into a video game
